• British activist fund TCI has asked Airbus to immediately abandon its plan to buy a 29.9% stake in Evidian (Atos).
  • Kering issues €1.5 billion in bonds in two tranches.
  • BHP: the stock suffers after the announcement of the results and the dividend cut.
  • HSBC: Q4 profit reaches $6.83bn. The bank is considering paying a special dividend of USD 0.21 per share.
  • Straumann: 2023 organic growth reached 15.7%. The margin declined slightly to 26%. It should be around 25% this year. An increased dividend of CHF 0.80 will be proposed.
  • Temenos: 2022 results are down. The group expects stable revenues this year, while banks are still reluctant to invest.
  • Swiss financial regulator Finma is reviewing comments made by Credit Suisse Chairman Axel Lehmann that outflows had stabilized in early December.
  • Shell completes purchase of Danish company Nature Energy Biogas for $2 billion.
  • Volkswagen may have to recall many vehicles after losing a court case against an NGO that accused it of illegal emissions software.
  • Verbio plans to become a European company (SE).
  • Interpump acquires 85% of Indoshell Automotive.
  • Kudelski refrains from selling its stake in iWedia.
  • Walmart dropped 3.5% in pre-market trading after the publication of an annual profit forecast that fell short of expectations, the retail giant also showing caution about the evolution of consumption in the United States, which could be affected by inflation.
  • Home Depot fell 3.8% in premarket trading in response to a lower-than-expected annual profit forecast on Wall Street amid rising costs and falling demand.
  • Meta Platforms advanced 2.2% in premarket trading as Facebook's parent company announced Sunday it is testing a monthly subscription-based service under certified accounts.
  • Microsoft Chairman Brad Smith will try to convince European authorities in a closed-door hearing on Tuesday that the U.S. software giant's $69 billion bid for Activision will boost competition, a European Commission document seen by Reuters shows.
  • General Mills - The food company raised its full-year organic sales and profit forecast on Tuesday, citing price increases, sending the stock up 2% in premarket trading.
  • Merck & Co announced Tuesday that Lagevrios, its COVID-19 treatment, did not reduce the risk of SARS-Cov-2 infection in people living with a patient infected with the virus.
  • Medtronic - The medical equipment maker reported better-than-expected quarterly earnings Tuesday on strong demand for its cardiology and diabetes devices, sending its stock price up more than 2% before the Wall Street opening.
  • Travere Therapeutics jumped 12% in pre-market trading after the U.S. Food and Drug Administration (FDA) approved its renal failure treatment.

The main results today: Walmart, The Home Depot, HSBC, Medtronic, Public Storage, Engie, Capgemini, Antofagasta, Straumann, Edenred, Worldline, Davide Campari...